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ABSTRACT
Cortical development is controlled by transcriptional
programs, which are orchestrated by transcription
factors. Yet, stable inheritance of spatio-temporal ac-
tivity of factors influencing cell fate and localization
in different layers is only partly understood. Here we
find that deletion of Dot1l in the murine telencephalon
leads to cortical layering defects, indicating DOT1L
activity and chromatin methylation at H3K79 impact
on the cell cycle, and influence transcriptional pro-
grams conferring upper layer identity in early progen-
itors. Specifically, DOT1L prevents premature differ-
entiation by increasing expression of genes that reg-
ulate asymmetric cell division (Vangl2, Cenpj). Loss
of DOT1L results in reduced numbers of progeni-
tors expressing genes including SoxB1 gene family
members. Loss of DOT1L also leads to altered cor-
tical distribution of deep layer neurons that express
either TBR1, CTIP2 or SOX5, and less activation of
transcriptional programs that are characteristic for
upper layer neurons (Satb2, Pou3f3, Cux2, SoxC fam-
ily members). Data from three different mouse mod-
els suggest that DOT1L balances transcriptional pro-
grams necessary for proper neuronal composition
and distribution in the six cortical layers. Further-
more, because loss of DOT1L in the pre-neurogenic
phase of development impairs specifically genera-
tion of SATB2-expressing upper layer neurons, our
data suggest that DOT1L primes upper layer identity
in cortical progenitors.
INTRODUCTION
Modifications of the epigenome, including histone modifi-
cations, play a crucial role in neuronal differentiation (1).
Dysregulation of specific epigenetic mechanisms have been
implicated in neurodevelopmental disorders (2,3). However,
only limited description on the impact of individual chro-
matin modifiers on epigenetic regulation during cortical de-
velopment is available (4,5).Moreover, the epigenetic mech-
anisms underlying the spatio-temporal expression of tran-
scription factors (TF) during central nervous system (CNS)
development are yet to be elucidated (6,7). During corti-
cal development, gradients of TF activity orchestrate neu-
ronal cell fate commitment (6,8,9). Examples of instructive
TF in cortical development are the SRY-box (Sox) family
members, namely SOX2, SOX4, SOX5 and SOX11 (10–12).
Further regulatory TF networks involved in neuronal dif-
ferentiation and cortical patterning have been extensively
described. Butmany of themolecularmechanisms that con-
trol, establish and maintain the hierarchy of TF cascades
are still unresolved. In particular, molecular mechanisms
that govern cell-intrinsic fate decision toward upper layer
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(UL) neuronal identity still remain obscure (13). By un-
known molecular adaptation processes, progenitors of the
cerebral cortex acquire a restrictive developmental poten-
tial over time. The cell fate restriction is indicated by the
observation that young progenitors can adapt their fate to
later developmental programs. In contrast, late progenitors
keep their fate information for UL even when transplanted
in younger brains (14,15). It is not clear yet at what stage of
development an UL fate is established and what might be
the underlying molecular mechanism.
Here, we report that activity of the Disruptor of telom-
eric silencing-like 1 (DOT1L) might prime UL neuronal
identity already at the beginning of the neurogenic phase.
DOT1L is a histone methyltransferase that mediates specif-
ically histone H3 lysine 79 (H3K79) mono- (me1), di- (me2)
and trimethylation (me3), although other enzymes may ex-
ist with the same function (16). DOT1L influences different
cellular processes such as proliferation, DNA repair, and
reprograming in some forms of leukaemia (17). DOT1L is
indispensable for early mouse development and promotes
proliferation, in particular if stem cells grow under differ-
entiating conditions (18,19). During organ development,
DOT1L is implicated in myocardiocyte differentiation, and
mainly acts as transcriptional activator (20,21). However,
in the forebrain, DOT1L also suppresses transcriptional ac-
tivation of endoplasmic reticulum (ER) stress programs in
primary cortical neurons in vitro (22). A growing body of
data describesDOT1L function in different cell types, where
it affects cell proliferation as well as other properties. But
studies that aim to reveal the physiological roles of DOT1L
rarely report on mechanisms or target genes that cause the
reported phenotypes. Therefore, we aimed to address the
function of DOT1L in balancing proliferation and differen-
tiation during CNS development, where in vivo target genes
are also unknown.
The data presented here show that DOT1L (i) prevents
premature cell cycle exit of progenitors, at least in part by
affecting asymmetric cell division, and (ii) supports tran-
scriptional programs characteristic for UL cell fate dur-
ing early cortical development. DOT1L thus primes pro-
genitors for UL gene expression and cell fate before UL
neuronal differentiation is thought to occur. Our data sug-
gest that the H3K79me epigenetic modification might pro-
vide early-established cell fate information that is able to be
transmitted to subsequent progenitor generations.
MATERIALS AND METHODS
Mice
Forkhead box G1 (Foxg1)-Cre/+ (23), Empty spira-
cles homeobox 1 (Emx1)-Cre/+ (24), and Nestin(Nes)-
CreER(T2)/R26R-(YFP) (25) animals were mated with
floxed Dot1l. Animals with the genotype Foxg1cre/+ or
Emx1cre/+;Dot1lflox/flox (cKO) were analyzed in compari-
son to littermates with Foxg1+/+ or Emx1+/+;Dot1lflox/+
(ctrl). ForNes-Cre line pregnant animals were injected with
200g/g body weight tamoxifen (Tmx) (#T5648, Sigma-
Aldrich, USA) and 100 g/g body weight progesterone
(#P0130, Sigma-Aldrich). Non Tmx exposed animals were
used as controls. Animal welfare committees of the Uni-
versity of Freiburg and local authorities approved all ani-
mal experiments (G12/13, G16/11). Genotyping was per-
formed using primers listed in Supplemental Table S1.
ChIP, ChIP-seq, and RNA-seq
ChIP-seq for H3K79me2 was performed from E12.5 entire
forebrains, which were acutely dissociated into single cells
and fixed as described (22). Data from E14.5 time point
derived from acutely isolated NPCs from cerebral cortex
(22). For H3K4me3 ChIP-seq E14.5 NPC cells were fixed
for 5 min at RT with 1% PFA, washed twice with ice-cold
PBS and lysed for 10 min on ice with lysis buffer (1% SDS,
10 mM EDTA, 50 mM Tris–HCl pH 8). Antibodies used
are listed in Supplemental Table S2. ChIP-seq samples were
sequenced on Illumina HiSeq2500 (paired end, multiplex-
ing run, 50 million/reads per sample). For ChIP followed
by qRTPCR E14.5 DT cortical tissue was used. This was
homogenized, fixed and afterward processed as described
above. For RNA-seq, RNA was extracted as described in
supplementary methods. The quality of the RNA was as-
sessed with a QIAxcel (#9001941, Qiagen, Germany) and
sequenced with an Illumina HiSeq2500. A paired end, mul-
tiplexing run was used for sequencing and generated 75
million/reads per sample.
In situ hybridization (ISH), Hematoxylin-Eosin (HE) stain-
ing, and immunostainings
ISH, HE staining, and immunostaining of brain tissue
and cultured cells was performed as previously described
(26,27). For ISH, probes listed in Supplemental Table S1
were applied. Antibodies used are listed in Supplemental
Table S2. Information about imaging and quantifications
are provided in the supplementary methods.
In utero electroporation (IUE)
IUE was carried out in C57BL/6 (Janvier Labs, Saint
Berthevin, France) time-pregnant mice as previously de-
scribed (28). Briefly, E12.5 pregnant mice were deeply anes-
thetized with isofluorane, and the uterine horns carrying
the embryos were exposed. One lateral ventricle per em-
bryo was injected with 1–2 l of plasmid DNA (DOT1L-
overexpression construct together with pDSV-mRFPnls, or
pDSV-mRFPnls alone) at a concentration of 2 g/l. Six
pulses of 30 V were delivered through the embryonic head.
The uterus was repositioned within the abdominal cav-
ity, and after suturing the embryonic development contin-
ued normally. At the designated time-points, the embryonic
brains were removed and fixed overnight in 4% PFA at 4◦C.
After extensive rinsing in PBS the brains were processed for
immunostaining.
Bioinformatics of RNA-seq and ChIP-seq
RNA-seq and ChIP-seq data were analyzed on the Galaxy
platform (29). RNA-seq FASTQ files were analyzed using
following tools: TrimGalore for trimming (30), TopHat2 for
read mapping (31,32), HTseq-count for read counting (33)
and DESeq2 for differential gene expression analysis (34).
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Bowtie2 for read mapping (35), MACS2 for peak calling
(36), DiffBind for differential binding (37) and deepTools2
for in-depth ChIP-seq analysis (38). Detailed analysis steps
are provided within the supplemental methods.
Statistical analysis
Statistical comparisons were performed with GraphPad
Prism 6 software. For in vivo experiments each n is a dif-
ferent animal. For in vitro experiments each n was obtained
from a different mESC differentiation. Exemplary data sets
for cell numbers and qRTPCRs passed the D’Agostino-
Pearson omnibus normality test. Cell numbers within a
width of 200 m of the cortex were normalized to the
area in each bin (cell/mm2) (Supplementary Figure S2C
and D), and compared using an unpaired, two-tailed Stu-
dent’s t-test (equal variances) or Welch’s t-test (unequal
variances). For qRTPCRs data analysis, Ct values nor-
malized to the house keeping gene Gapdh were compared
using an unpaired, two-tailed Student’s t-test (equal vari-
ances) or Welch’s t-test (unequal variances). For data pre-
sentation, Ct values are expressed as log2(fold change)
and shown as mean ± SEM. These values were calculated
from three technical replicates from each independent n.
The error propagation formula was used to assess correct
SEM values. For statistical analyses of  -TUBULIN im-
munostainings, Fisher’s exact test on a 2 × 2 contingency
table with small sample size was used.
RESULTS
Dot1l-deficiency impairs cortical development
In the developing cerebral cortex, Dot1l is expressed in the
progenitor zone and cortical plate between E11.5 and the
adult stage (Figure 1A, B). In quantitative real-time PCR
(qRTPCR), Dot1l was significantly elevated at the early
neurogenesis stage E14.5 compared to E11.5 (Figure 1C).
To elucidate DOT1L function in the cerebral cortex, we
generated a DOT1L conditional knockout mouse (Dot1l-
cKO) using a Foxg1-Cre driver line (23). Dot1l-cKO mice
displayed a significant depletion of Dot1l mRNA in the te-
lencephalon at E12.5 and E14.5 (Figure 1D). Dot1l-cKO
animals died within minutes after birth. Histological char-
acterization at P0 showed that Dot1l-cKO animals had mi-
crocephaly affecting ventral and dorsal structures (Figure
1E). The cortical plate of mutant brains was generally thin-
ner compared to controls and cells appeared less densely
packed. In addition, the hippocampus was disorganized
with fewer cells in the dentate gyrus at P0 (Figure 1E). Het-
erozygote Foxg1-Cre mice are reported in some studies to
have a mild cortical phenotype (39,40). We therefore also
used an Emx1-Cre driver line (24) to delete Dot1l. Nissl
staining ofEmx1-Cre inducedDot1l-cKO at P0 showed that
microcephaly was less obvious in these mutant brains com-
pared toFoxg1-Cremediated deletion ofDOT1L.However,
the cellular composition of the cortical plate seemed to be
different between mutant and control brains (Supplemen-
tary Figure S1A). The hippocampus of Emx1-Cre induced
Dot1l-cKO was also disorganized, especially in the dentate
gyrus. In all, we observed a comparable phenotype between
Foxg1-Cre and Emx1-Cre. But as the microcephalic phe-
notype was stronger in Foxg1-Cre Dot1l-cKO, we contin-
ued with further phenotypic characterizations in this mouse
line.
Dot1l-deficiency reduces the number of progenitors, neuroge-
nesis as well as distribution of neuronal subtypes
Immunostaining experiments at E18.5 revealed fewer
Paired box 6 (PAX6)-positive progenitors in the Dot1l-
cKO compared to controls (Figure 2A). Deep layer (DL)
neurons marked by T-box brain 1 (TBR1) and B cell
leukemia/lymphoma 11B (BCL11B/CTIP2) (41) were sig-
nificantly increased in the Dot1l-cKO brains (Figure 2A).
In contrast, upper layer (UL) neurons, identified by Special
AT-rich sequence binding protein 2 (SATB2) (42), signifi-
cantly decreased upon DOT1L-deficiency. At E14.5,Dot1l-
deficient mice exhibited similar changes with decreased
numbers of PAX6-, and increased numbers of TBR1- and
CTIP2-expressing cells compared to controls (Figure 2B).
TBR2-expressing intermediate progenitor cells (IPCs) also
decreased at E14.5 (Figure 2C). In situ hybridization (ISH)
studies suggested altered expression of Reelin (Reln) (43)
(Supplementary Figure S2A), and a thinner expression do-
main of LIM homeobox protein 2 (Lhx2) in the knockout
as compared to control mice (Supplementary Figure S2B).
Together, these alterations ofmarker gene expression sug-
gested that Dot1l-cKO reduced neural progenitor cells and
promoted their premature differentiation into DL neurons,
at the expense of UL neurons. To compare quantitated cell
numbers in the microcephalic and control cortices, we di-
vided the cortical plate into 10 bins and determined cell
numbers in each bin. This approach allowed us to normalize
to the variable height of the cortices in the different geno-
types (Supplementary Figure S2C, D). However, the signif-
icant changes observed within specific bins (Figure 2A–C)
did not resolve whether they resulted from differences in
generation or rather through aberrant distribution of the
mature neurons in the cortical plate. To address the ques-
tion of differences in neurogenesis or distribution of cells,
we first quantified the total number of DAPI-positive cells
in the cortical plate at E14.5 and E18.5. This revealed in-
creased numbers of cells at E14.5 and decreased numbers
at E18.5 in DOT1L-deficient mice as compared to con-
trols (Figure 2D). These findings suggested that increased
cell proliferation in the early neurogenic phase, premature
progenitor differentiation and reduction of the progenitor
pool could account for the phenotype of the Dot1l-cKO
mice. To test for a potential increase in cell proliferation in
early developmental stages upon Dot1l-cKO, we labeled S-
phase cells by a 1h BrdU pulse, and quantified numbers of
BrdU- and Ki67-positive cells at E12.5 and E14.5 (Figure
2E, F). Consistent with our prediction,Dot1l-cKOmice had
significantly increased cell proliferation at E12.5 compared
to controls, and decreased proliferation at E14.5 (Figure
2F). In addition, a significant higher fraction ofDot1l-cKO
cells left the cell cycle (BrdU-labeled only, leaving fraction
(LF)) at E12.5 compared to control cells. At E14.5 the num-
ber of proliferating cells and the cycling fraction (BrdU-
and Ki67-positive, cycling fraction (CF)) decreased in mu-
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Figure 1. Dot1l is expressed in the developing mouse cerebral cortex and prevents microcephaly. (A, B) In situ hybridization (ISH) of cortical sections
using Dot1l-antisense probe at different developmental time points (E12.5-E18.5) reveals expression of Dot1l during mouse brain development (A), and
in adult brains (B). Annotations: Cortical plate (CP), intermediate zone (IZ), subventricular/ventricular zone (SVZ/VZ), cornu ammonis (CA), dentate
gyrus (DG). Scale bars: overview 500 m, magnification 50 m. (C) qRTPCR analysis of Dot1l expression at different embryonic stages (E13.5-E17.5, n
= 3) and in adult (n = 4) cortical tissue normalized to E11.5. (D) qRTPCR analysis of Dot1l expression in Foxg1-Cre Dot1l-cKO animals normalized to
values of control (ctrl) animals (n = 6) at E12.5 in the entire forebrain and E14.5 in dorsal (DT) and ventral telencephalon (VT). (E) Nissl stained sections
of P0 ctrl and Foxg1-CreDot1l-cKO brains. Black squares in upper panels represent higher magnification images depicted below. Scale bars: 500 m. Data
of qRTPCRs are presented as mean ± SEM. P-values were calculated using unpaired, two tailed Student’s t-test: *P < 0.05, **P < 0.01, ***P < 0.001.
BrdU pulse chasing experiments supported the finding of
increased proliferation in the early neurogenic phase, pre-
mature progenitor differentiation and reduction of the pro-
genitor pool in Dot1l-cKO mice.
Next, we quantified the total numbers of PAX6-, TBR2-
, TBR1-, CTIP2- and SATB2-expressing cells. Loss of
DOT1L reduced the total number of PAX6- and SATB2-
positive cells at E18.5 compared to controls, whereas to-
tal numbers of TBR1- and CTIP2-positive neurons did
not change (Figure 2H). At E14.5, the total number of
PAX6-positive cells remained constant, but we observed
more TBR1- and CTIP2-expressing cells in the Dot1l-cKO
compared to controls (Figure 2I). The total number of
TBR2-positive cells was constant between genotypes (Fig-
ure 2J). In summary, Dot1l-cKO decreased the generation
of PAX6-positive progenitors and SATB2-expressing UL
neurons compared to controls. Loss of DOT1L caused pre-
mature appearance of more TBR1- and CTIP2-expressing
cells. The total number of these DL neurons was similar be-
tween the genotypes at the later embryonic stage E18.5. The
quantitative differences of TBR1- and CTIP2-positive neu-
rons within different bins of the cortex between DOT1L-
deficient and control animals thus reflected altered distribu-
tion of these neuronal subtypes at E18.5. Neither increased
apoptosis and/or expression of ER stress genes (22) were
observed inDot1l-cKO compared to controls to account for
the altered numbers of cells (Supplementary Figure S3A-E).
We next assessed whether Emx1-Cre driven Dot1l-cKO
mice had comparable phenotypic alterations to using
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Figure 2. Dot1l-cKO leads to decreased numbers of progenitors and UL neurons, as well as altered distribution of DL neurons. (A) Left: Immunos-
tainings of E18.5 forebrain sections for PAX6, TBR1, CITP2, and SATB2 in red, DAPI in blue. Annotations: Cortical plate (CP), intermediate zone
(IZ), subventricular/ventricular zone (SVZ/VZ), Scale bar: 100 m. Right: Quantification of number of stained cells/mm2 within each individual bin
out of 10 bins spanning the entire cortex from VZ (bin 10) to the marginal zone (bin 1) in a width of 200 m (PAX6 n = 3, TBR1 n = 3, CTIP2 n =
3(ctrl)/4(Dot1l-cKO), SATB2 n = 3) for ctrl and Foxg1-Cre Dot1l-cKO. (B) Immunostainings of E14.5 forebrain sections for PAX6, TBR1, and CTIP2
(left) and quantification of total number of stained cells/mm2 (PAX6 n = 4(ctrl)/6(Dot1l-cKO),TBR1 n = 4, CTIP2 n = 4) in 10 bins (right). Scale bar:
100 m. (C) Immunostainings (left) and quantification (right) of TBR2-positive cells at E14.5 and E16.5 (n= 3). (D) Total number of DAPI-stained nuclei
obtained from forebrain sections at E14.5 and E18.5 in a width of 200 m (n = 3(ctrl)/4(Dot1l-cKO)). (E) Representative images of immunostainings of
E12.5 and E14.5 forebrain sections for BrdU (red), Ki67 (green), and DAPI (blue). Scale bar: 200 m. (F) Quantification of number of BrdU and Ki67
stained cells in a width of 200 m (n = 4). (G) Quantification of BrdU+/Ki67- cells, representing the leaving fraction (LF), and BrdU+/Ki67+ cells rep-
resenting the cycling fraction (CF) in 200 m width of the cortex at E12.5 and E14.5. (H) Total numbers of PAX6, TBR1, CTIP2, or SATB2-positive cells
at E18.5 in 200 m width of the cortex, as determined from the sum of positive cells for the respective markers counted in B. (I) PAX6, TBR1, or CTIP2
positive cells at E14.5 in 200mwidth of the cortex, as determined from the sum of positive cells for the respective markers counted in C. (J) TBR2-positive
cells at E14.5 and E16.5 in 200 m width of the cortical plate as determined from the sum of positive cells for the different time points counted in D. All
data are from ctrl and Foxg1-Cre Dot1l-cKO and represented as mean ± SEM. P-values were calculated using unpaired, two tailed Student’s t-test: *P <
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tification of layer markers at E18.5 revealed a compara-
ble pattern of Emx1-Cre to Foxg1-Cre mediated deriva-
tion of Dot1l-cKO mice (Supplementary Figure S4A). In
both cases, deletion of DOT1L either through Emx1-Cre
or Foxg1-Cre reduced the numbers of PAX6-, TBR2-, and
SATB2-cells, and led to altered distribution of TBR1- and
CTIP2-neurons (Supplementary Figure S4A, B).
In all, we concluded that the Dot1l-cKO on one hand in-
creased cell proliferation in the early neurogenic phase, and
prematurely reduced the progenitor pool through neuronal
differentiation. On the other hand, we observed aberrant
cell positioning of DL neurons and decreased numbers of
SATB2-positiveULneurons inDOT1L-deficient compared
to control brains.
H3K79me2 marks genes expressed in progenitors and UL
neurons
Genome-wide sequencing served as a baseline to explore the
molecular nature of the phenotypic alterations occurring in
Dot1l-cKOmice.We analyzed the pattern ofH3K79me2 de-
posited on the chromatin in wild-type animals using chro-
matin immunoprecipitation (ChIP) followed by genome-
wide sequencing (ChIP-seq) at E12.5 and E14.5. Addition-
ally, at E14.5 we performed ChIP-seq analysis of H3K4me3
that marks active transcription (44), as well as genome-wide
sequencing of mRNA (RNA-seq) of Dot1l-cKO and con-
trols in the dorsal telencephalon.
RNA-seq revealed 1976 significantly (adjusted P-
value ≤ 0.05) differentially expressed (DE) genes upon
Dot1l-cKO. We investigated the distribution of the
H3K4me3 and H3K79me2 marks within the gene bodies
(spanning from the transcriptional start site (TSS) to the
transcriptional end site (TES)) and adjacent ±4 kb of the
1976 DE genes (Figure 3A, lower panel). Almost all DE
genes were marked with H3K4me3, whether they showed
decreased or increased expression upon Dot1l-cKO com-
pared to controls (Figure 3A). To reveal any correlations
between H3K79me2 and transcriptional alterations of
the 1976 target genes, we used K-means clustering with
a preset of four clusters. Two clusters contained genes
with increased expression, of which up cluster 1 contained
260 genes with higher levels of H3K79me2, compared to
up cluster 2 with 1054 genes (Figure 3B). The other two
clusters contained genes with decreased expression. 104
genes in down cluster 1 were transcriptionally decreased
and had substantial H3K79me2 modification up- and
downstream of the TSS; 558 down cluster 2 genes had
decreased expression and H3K79me2 mainly downstream
of the TSS (Figure 3A, upper and lower panel). Quantita-
tive analyses of H3K4me3 and H3K79me2 levels between
the four clusters showed similar distribution of values for
H3K4me3 in all clusters except for up cluster 2, which
had slightly lower levels compared to the other clusters
(Figure 3B). In contrast, H3K79me2 levels were higher
for genes with decreased transcription upon Dot1l-cKO
(down cluster 1 and 2, Figure 3B), compared to the genes
with increased transcription. As shown in Figure 3C,
most of the transcriptional alterations upon Dot1l-cKO
were moderate, and DE genes with high enrichment for
H3K79me2 both transcriptionally increased or decreased.
Those genes that did not change upon Dot1l-cKO overall
had a lower H3K79me2 coverage compared to the DE
genes (Supplementary Figure S5A). Together this data
indicated variability of H3K79me2 patterns. On one hand
this variability was observed with regard to the location
within the genomic region, whereby H3K79me2 was
either enriched at the TSS or it was deposited over larger
regions, including entire gene bodies. On the other hand,
H3K79me2 was present at genes that transcriptionally
increased or decreased upon DOT1L-deletion compared
to controls.
We concluded that for identification of DOT1L tar-
get genes detailed, locus-specific analyses of H3K79me2
patterns together with expression changes upon DOT1L-
deficiency might be necessary. Our further analyses there-
fore contain both information, H3K79me2 pattern and
gene expression. We hypothesized from this data set, that
direct DOT1L targets might be enriched among genes
which were highly marked by H3K79me2 and decreased
upon DOT1L-deficiency. Thus, our further experimenta-
tion aimed (1) to identify specific DOT1L target genes that
might be causing the observed phenotype and (2) to test this
hypothesis.
With the aim to identify specific DOT1L target genes,
we considered a potential contribution of the reduced
Foxg1 expression (caused by the Cre knockin) could
lead to the transcriptional alterations observed in Dot1l-
cKO (39). Therefore, we performed RNA-seq of heterozy-
gote Foxg1-Cre forebrains and intersected the 402 signif-
icantly DE genes with the 1976 DE genes revealed from
DOT1L-deficient forebrains (Supplementary Figure S5B).
We identified 132 shared genes, 70 of which did not carry
H3K79me2 (Supplementary Figure S5C), and excluded
these 132 DE transcripts from our further analyses.
The phenotype of the developing cortical plate sug-
gested that the Dot1l-cKO affected both progenitor prolif-
eration and neuronal differentiation. We therefore analyzed
whether DOT1L-mediated H3K79me2 modification corre-
lated with expression changes of genes normally expressed
in the ventricular zone (VZ), subventricular zone (SVZ),
DL, UL, and layer 1 (the classification of these genes was
extracted from various publications, which are summarized
in Supplemental Table S3). The corresponding heatmap of
the H3K79me2 ChIP-seq profile of the selected transcripts
in the different cellular subtypes revealed that out of 18
selected genes expressed in VZ and SVZ progenitors, 16
carried H3K79me2 at E12.5, and 18 at E14.5, respectively.
Eleven of these 18 transcripts decreased upon Dot1l-cKO
(Figure 3D). Of 14 selected genes expressed in DL neurons,
9 had few or no H3K79me2 marks at E12.5, and 7 at E14.5,
respectively, and 11 of these DL transcripts increased upon
loss of DOT1L. 15 genes were selected because their expres-
sion has been identified in UL neurons. Thirteen out of 15
genes were already marked with H3K79me2 at E12.5, and
11 at E14.5. 8 of this set of candidate genes decreased in
Dot1l-cKO forebrains compared to controls (Figure 3D).
qRTPCR of a subset of these selected candidates confirmed
the transcriptional changes observed by RNA-seq (Figure
3E, left panel).
It is of note that the H3K79me2 pattern differed sub-
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Figure 3. Genes expressed in VZ, SVZ, and UL of the cortical plate are enriched with H3K79me2 and their expression decreased significantly uponDot1l-
cKO. (A) Lower panels: Heatmaps of enriched (blue) and non-enriched (red) read counts forH3K4me3 (E14.5) andH3K79me2 (E12.5 and E14.5) along the
gene body (scaled to 4 kb) including the flanking regions +/-4 kb after ChIP-seq from wild type forebrains, arranged in four K-means clusters according
to H3K79me2 levels at E14.5. All DE genes upon Foxg1-Cre Dot1l-cKO at E14.5 including their expression levels according to RNA-seq in log2(fold
change) are displayed (right panel); blue: increased, red: decreased expression. Upper panels: distribution of ChIP enrichment as log2(ChIP/Input) for the
individual histone marks over all genes and subdivided according to the four K-means clusters, indicating highest enrichment around the TSS and in down
cluster 1 (green), and lower enrichment toward the TES and in down cluster 2 (orange), up cluster 1 (black) and 2 (blue). (B) log2(ChIP/Input) average at the
TSS ±250 bp of H3K4me3 and H3K79me2 in the four clusters (down cluster 1, down cluster 2, up cluster 1, up cluster 2) of differentially expressed genes.
(C) Correlation analysis of H3K4me3 and H3K79me3 levels (log2 (ChIP/Input) versus expression of genes (log2(fold changes)), represented according to
K-means clusters. (D) Arrangement of DE genes, expression of which is confined to VZ (dark green), SVZ (light green), deep layers (brown), upper layers
(orange), and layer 1 (yellow). Given are the gene names, fold changes in RNA-seq data compared to ctrl (left panel), and heatmaps along the gene body
(+/-4 kb, including TSS and TES) of H3K79me2 pattern (blue: strong enrichment, red: no enrichment) for the respective genes at E12.5 and E14.5 in
wild type animals (right panel). (E) qRTPCR validation of selected layer-specific genes, color-coded as in D (left panel) (Otx1, Ccnd1 and Cyp39a1 n = 3;
Lhx5, Lhx2 and Igfbp1 n = 4; Nfib n = 5, Arx, Ppp1r1b, Dkk3, Glra2, Cux2 and Reln n = 6; Satb2 n = 8). High resolution representation of H3K79me2
distribution at the respective genes from TSS to TES in E12.5 and E14.5 wild type dorsal telencephalon represented as log2(ChIP/input) (right panel),
indicating stronger enrichment in progenitor and UL compared to DL expressed genes. All qRTPCR data are represented as mean ± SEM. P-values were
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fore used locus-specific high resolution analyses to identify
gene-specific H3K79me2 enrichments, which we hypothe-
sized serve best to identify direct DOT1L target genes. We
correlated expression levels and such H3K79me2 profiles in
progenitors and neurons. This analysis indicated higher en-
richment of the histone modification in progenitors com-
pared to neurons (Figure 3E, right panel). Among neuronal
genes, those with DL expression (Dickkopf WNT signaling
pathway inhibitor 3 (Dkk3), Protein phosphatase 1 regula-
tory inhibitor subunit 1B (Ppp1r1b)) had lower H3K79me2
enrichment thanUL expressed genes (Satb2,Cut like home-
obox 2 (Cux2)). Taken together, ChIP-, RNA-seq, and
qRTPCRdata supported our hypothesis that directDOT1L
targets are most likely, but not exclusively, identified by
high levels of H3K79me2 and decreased expression upon
Dot1l-cKO. Among genes expressed by specific cell popula-
tions during cortical development, we identified Insulin like
growth factor 2 mRNA binding protein 1 (Igf2bp1),Ortho-
denticle homeobox 1 (Otx1),Cyclin D1 (Ccnd1), Lhx2 and
Nuclear factor I B (Nfib) as novel targets in progenitors, and
Satb2 as well as Cux2 as UL targets. From transcripts ex-
pressed by DL neurons, only Sox5 classified as DOT1L tar-
get under our selection criteria. In addition, these data sug-
gested to us that DOT1L might infer neuronal cell fate in-
formation because we identified target genes such as Satb2
andCux2. These latter genes are expressed by late born neu-
rons, but were marked with H3K79me2 already at a devel-
opmental stage dominated by proliferative events, i.e. E12.5.
DOT1L and H3K79me2 activate transcription of HMG-
domain transcription factors
We aimed to identify further DOT1L target genes, which
fulfilled the selection criteria of decreased transcription and
substantial H3K79me2 at E14.5. We observed enrichment
of many HMG-domain TF-family members, namely Sox1,
Sox2, Sox4, Sox5, Sox6, Sox8, Sox10, Sox11, Transcription
factor 7 like 1 (Tcf7l1), Tcf7l2,WD repeat and HMG-box
DNAbinding protein 1 (Wdhd1) and Thymocyte selection-
associated HMG box (Tox1). With the exception of the
oligodendrocyte-expressed Sox10 (45), all HMG TF were
marked with H3K79me2 at E12.5 and E14.5 (Figure 4A).
qRTPCR verified 7 out of 12 HMG TF with significantly
decreased expression upon Dot1l deletion in vivo (Figure
4A).
The activating effect of DOT1L on HMG TF transcrip-
tion was not restricted to progenitors, but was also evident
for family members active in differentiated neurons (Fig-
ure 4A), again indicating that DOT1L might act beyond
cell proliferation on neuronal differentiation. Immunos-
taining analysis for SOX1 and SOX2 and confirmed de-
creased expression in DOT1L-deficient mouse forebrains
at E14.5 and E16.5 in the VZ compared to controls (Fig-
ure 4B). As the total number of SOX1- and SOX2-positive
cells decreased, we concluded that DOT1L function af-
fects the number of these progenitors (Figure 4E). SOX4,
SOX5, and SOX11 are expressed in differentiated neu-
rons. SOX5 is expressed in DL neurons, and we quantified
significantly increased numbers of SOX5-positive cells in
Dot1l-deficient forebrains at E14.5 (Figure 4C) and E16.5
(Figure 4D) compared to controls. In contrast, SOX4 and
SOX11, which are expressed in DL and UL neurons, sig-
nificantly decreased in Dot1l-cKO (Figure 4C, D). While
loss ofDOT1L decreased generation of SOX4-positive cells,
as revealed by the reduced total number of SOX4-positive
cells compared to wild type animals, numbers of SOX5- and
SOX11-neurons did not change (Figure 4F, G). This indi-
cated that DOT1L-deficiency most likely affected distribu-
tion of SOX5- and SOX11-expressing neurons. qRTPCR
after H3K79me2 ChIP revealed less enrichment of marked
chromatin in E14.5Dot1l-cKO forebrains compared to con-
trols around the TSS of SOX4, 11 and 5 (Figure 4H), sug-
gesting a direct effect of DOT1L on expression of these neu-
ronal genes.
This data supported the view that DOT1L and
H3K79me2 (i) directly regulated HMG TF expression
in vivo, (ii) decreased the number of progenitors, and (iii)
impacted on the generation and distribution of cortical
plate neurons, depending on their respective subtype.
DOT1L-deficiency decreases transcription of genes affecting
the cell cycle and the division mode
We used pathway analyses of DE genes upon Dot1l dele-
tion to identify further in vivo cortical DOT1L target
genes. These analyses indicated enrichment for cell cycle-
related genes (Supplementary Figure S6A). Fifteen poten-
tial DOT1L target genes implicated in cell cycle control
carried H3K79me2 modifications and mainly affect G1/S
phase. Cyclin D1 (Ccnd1) and E2F transcription factor
(E2f7), which are important for G1/S transition (46), were
the only two genes from this set of selected genes with signif-
icantly altered expression as revealed using qRTPCR anal-
yses of control and Dot1l-cKO dorsal forebrains (Supple-
mentary Figure S6B).
Despite lower numbers of cells in S-phase at E14.5,Dot1l
deletion did not result in significantly decreased numbers of
M-phase cells, as determined byHistone H3 serine 10 phos-
phorylation (H3S10ph) immunostaining (Supplementary
Figure S6C). This seemingly contradicting findingmight in-
dicate an altered M-phase. We hypothesized that at E14.5,
fewer cells entered S-phase in the Dot1l-cKO mice (Figure
2F) and that these cells accumulated in M-phase, which re-
sulted in comparable numbers to control brains with an un-
perturbed cell cycle. To test this hypothesis, we analyzed
genes that are known to influence specifically M-phase with
regard to (i) occurrence of H3K79me2 as indicator of di-
rect DOT1L effects, and (ii) decreased gene expression in
the RNA-seq data. In support of our hypothesis, ChIP-seq
data revealed Vang-like 2 (Vangl2), and Centromere pro-
tein v (Cenpv) and j (Cenpj), which carried H3K79me2
modifications at E12.5 and E14.5, and Ankyrin repeat do-
main 6 (Ankrd6), which gained H3K79me2 at E14.5 (Fig-
ure 5A). These genes influence M-phase progression and
prevent premature progenitor differentiation through asym-
metric cell division by maintaining a horizontal cleavage
plane (47–49). RNA-seq and qRTPCR validation showed
that Vangl2 and Cenpv expression significantly decreased
upon Dot1l deletion at E12.5, and all four genes decreased
in expression compared to controls at E14.5 (Figure 5A, B).
We quantified the number of cells in the VZ with an-
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Figure 4. Sox family members are direct targets of DOT1L during cortical development in vivo and in vitro. (A) Left panel: Differences in expression
levels of Sox family members in log2(fold change) in Foxg1-Cre Dot1l-cKO compared to ctrl in RNA-seq (n = 3) (white bars) and qRTPCR validations
(gray bars, n = 6). Right panels: high resolution representation of H3K79me2 enrichment in log2(ChIP/Input) at E12.5 and E14.5 of the indicated genes,
which are subdivided according to expression mainly in progenitors or differentiated neurons. (B) Representative images (left panels) and quantifications
(cells/mm2 in 10 bins, right panels) of immunostainings of SOX1 (n = 4) and SOX2 (n = 3) at E14.5, and SOX1 (n = 3) at E16.5. Scale bar: 100 m. (C)
Representation as in B for SOX4 (n = 3), SOX5 (n = 4), and SOX11 (n = 3) at E14.5. (D) Representation as in B for SOX4 (n = 4), SOX5 (n = 3), and
SOX11 (n = 4) at E16.5. (E) Total numbers of SOX1- and SOX2-positive cells at E14.5 and E16.5 in 200 m width of the cortex, as determined from the
sum of positive cells for the respective markers counted in B for ctrl and Foxg1-CreDot1l-cKO. (F) Total numbers SOX4-, SOX11-, and SOX5-positive cells
at E14.5 in 200 mwidth of the cortex, as determined from the sum of positive cells for the respective markers counted in C. (G) Total numbers of SOX4-,
SOX11- and SOX5-positive cells at E16.5 in 200 m width of the cortex, as determined from the sum of positive cells for the respective markers counted
in D. (H) ChIP-qPCR analysis of H3K79me2 levels (% Input) of E14.5 ctrl and Foxg1-Cre Dot1l-cKO at the promotor region of Sox4, Sox5, and Sox11
(n = 4). All data are from ctrl and Foxg1-Cre Dot1l-cKO and represented as mean ± SEM. P-values were calculated using unpaired, two tailed Student’s
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Figure 5. DOT1L induces transcription of genes implicated in asymmetric cell division. (A) RNA-seq expression data (Foxg1-Cre Dot1l-cKO vs ctrl, left
panel) and high resolution representation of H3K79me2 distribution along the respective gene in wild type forebrains in log2(ChIP/input) at E12.5 and
E14.5 of Vangl2, Cenpv, Cenpj and Ankrd6. (B) qRTPCR validation of the expression levels of the genes shown in A in Foxg1-CreDot1l-cKO compared to
ctrl at E12.5 and E14.5 (n= 6). (C) Representative immunostainings for  -TUBULIN (red) and DAPI (blue) of E12.5 and E14.5 VZ of ctrl and Foxg1-Cre
Dot1l-cKO (middle panels). For better visualization of the  -TUBULIN staining, the red channel was split and inverted (upper panel). Cells with different
orientation of the cleavage planes are depicted exemplarily with red circles. Quantification of the number of cells (represented as black dots) that presented
different angles of the cleavage plane in respect to the ventricle surface within increments of 15◦ is shown in the lower panel for ctrl (n= 57 at E12.5, n= 105
at E14.5) and Foxg1-CreDot1l-cKO (n= 66 at E12.5, n= 68 at E14.5). Statistical comparison betweenDot1l-cKO vs ctrl of all dividing cells with cleavage
planes below 45◦ or above 45◦ was performed with one-tailed Fisher’s exact test at E12.5 or E14.5.P-values are shown below the quantifications: *P< 0.05.
Scale bars: 25 m. (D) qRTPCR analysis for Vangl2, Cenpv, Cenpj and Ankrd6 in neural progenitor cells differentiated from mESCs after pharmacological
inhibition of DOT1L for 48h with two different inhibitors, SGC0946 (white bars) and EPZ5676 (gray bars) compared to DMSO treated ctrl cells (n = 4).
All data are presented as mean ± SEM. P-values were calculated using unpaired, two tailed Student’s t-test: *P < 0.05, **P < 0.01.
crements at E12.5 and E14.5 after  -TUBULIN immunos-
taining. Loss of DOT1L resulted in significantly more cells
with a cleavage plane parallel to the ventricular surface at
E14.5, which is a hallmark of asymmetric division (Figure
5C). To ascertain that DOT1L activity impacts on tran-
scription of Vangl2, Cenpv, Cenpj, and Ankrd6, we differen-
tiated mouse embryonic stem cells (mESC) into radial glial-
like cells (RGLC) in vitro (50). Interference with DOT1L
activity by applying the specific inhibitors SGC0946 or
EPZ5676 to RGLC for 48h led to significant lower levels
of H3K79me2 modification compared to DMSO treated
controls (Supplementary Figure S6D, E).DOT1L-inhibited
RGLC expressed significantly less Vangl2 and Cenpj com-
pared to controls (Figure 5D). Taken together, the data
showed that DOT1L activity promoted transcription of
genes implicated in asymmetric cell division in vivo and in
vitro.
DOT1L activates transcriptional programs governing UL
neuronal cell fate
Phenotypically, Dot1l-cKO resulted in premature cell cycle
exit of progenitors and altered numbers or distribution of
neurons in the developing cortical plate. We identified mod-
erate, but significant changes of the transcription levels of
cell-cycle regulating genes Ccnd1, E2f7, Vangl2, and Cenpj,
that might account for the observed differences of DOT1L-
deficient progenitors. However, in addition to progenitor-
assigned transcripts, our data revealed that subsets of genes
usually expressed in differentiated neurons (for example
Satb2, Cux2, Sox 4, 11, 5) were marked with H3K79me2
modification, and that their expression decreased upon loss
of DOT1L (Figure 3E, 4A). This finding together with the
moderate transcriptional changes of cell cycle regulating
genes, fostered the hypothesis that DOT1L might activate
specifically transcriptional programs of differentiated neu-
rons. To test this hypothesis, we analyzed a set of genes,
which are mainly expressed by differentiated neurons and
that are described to mark either DL (Tbr1, Slit guidance
ligand 1 (Slit1), Crystallin mu (Crym), Synaptotagmin 9
(Syt9), Dkk3, Synuclein alpha (Scna), Adenylate cyclase
1 (Adcy1)) or UL (Satb2, Pou3f3 (POU domain class 3
transcription factor 3), Cux1, Cux2) (see Supplemental Ta-
ble S3 for references) neurons. Interestingly, the transcripts
expressed from UL neurons (Satb2, Pou3f3, Cux1, and
Cux2)were marked with H3K79me2 already at E12.5 (Fig-
ure 6A), and their expression decreased upon Dot1l-cKO
compared to controls. From the selected genes mainly ex-
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Figure 6. DOT1L activates transcriptional programs governing UL neuronal cell fate. (A) qRTPCR expression analysis of genes expressed in UL cortical
neurons in Foxg1-Cre Dot1l-cKO compared to ctrl at E14.5 (n = 6, left panel) and high resolution representation of H3K79me2 distribution from TSS
over the respective gene body in wild type forebrains in log2(ChIP/input) of genes that are expressed in UL or DL cortical neurons at E12.5 and E14.5.
(B) qRTPCR expression analysis of genes expressed in UL cortical neurons in Foxg1-Cre Dot1l-cKO compared to ctrl at E12.5 (n = 6). (C) ChIP-qPCR
analysis of H3K79me2 levels (% Input) in E14.5 ctrl (white bars) and Foxg1-Cre Dot1l-cKO (gray bars) forebrains, at the promotor of genes that are
expressed in UL or DL cortical neurons (n = 4). (D) Upper panel: Representative image of immunostainings of cortical sections from E16.5 animals for
PAX6, TBR2, TBR1, CTIP2 or SATB2 (green), RFP (red) andDAPI (blue) within their main expression domains, after in utero electroporation of DOT1L
overexpression plasmid at E12.5. RFP marks electroporated cells, which assumingly overexpress DOT1L. Lower panel: Quantification of electroporated
cells (RFP) that co-expressed PAX6, TBR2, TBR1, CTIP2 and SATB2, given as percentage of the total number of RFP/DOT1L OE cortical cells within
the main expression domains/layers of the respective layer marker at E16.5 (PAX6 n = 3(ctrl)/4(Dot1l-cKO), TBR2 n = 3, TBR1 n = 3, CTIP2 n = 3,
SATB2 n= 3). (E) Distribution of RFP-positive cells at E16.5 after in utero electroporation at E12.5 (left panel). The graph below the representative images
shows the percentage of RFP-positive cells in each bin from the total RFP-positive cells determined in the 10 bins. Percentage of SATB2/RFP-positive
cells (middle panel) or TBR1/RFP-positive cells (right panel) at E16.5 after in utero electroporation at E12.5. The graphs below the representative images
show the percentage of SATB2/RFP- or TBR1/RFP-positive cells from the total RFP-positive cells in each bin (total RFP n = 5, RFP/SATB2 n = 3,
RFP/TBR1 n = 6(ctrl)/5(Dot1l-cKO)). Data are presented as mean ± SEM. P-values were calculated using unpaired, two tailed Student’s t-test: *P <
0.05, **P < 0.01, ***P < 0.001.
H3K79me2, whereas the six other DL candidate genes were
hardly marked. In support of our earlier hypothesis that
strong enrichment of H3K79me2 is followed by transcrip-
tional decrease upon Dot1l-cKO, expression of the selected
UL genes significantly decreased already at E12.5, and also
at E14.5 (Figure 6A, B). In contrast, upon Dot1l deletion,
the set of DL markers either increased or did not change
compared to controls at E14.5.
As protein expression of the UL marker genes is de-
tectable mainly during late neurogenesis, but we observed
transcription already at E12.5, we used qRTPCR to reveal
the mRNA abundance of these candidates during cortical
development. In vivo in the dorsal telencephalon, Satb2,
Pou3f3, Cux1, and Cux2 transcripts significantly increased
from E11.5 to E13.5, and also toward E14.5-E15.5, but de-
creased in later embryonic and in the adult stage (Supple-
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weremarked withH3K79me2 already at E12.5 (Figure 6A),
we hypothesized that transcription of these UL genes (1)
might be marked epigenetically by H3K79me2 early in de-
velopment and (2) would be transcriptionally influenced
through DOT1L. H3K79me2 ChIP and qRTPCR of the
region around the TSS of the selected UL and DL genes
confirmed enrichment ofH3K79me2 for theUL genes. This
H3K79me2 enrichment was significantly lost in Dot1l-cKO
compared to controls (Figure 6C). DL genes were hardly
enriched for H3K79me2 modification (Figure 6A, C), and
we could not detect significant alterations upon loss of
DOT1L, except for Tbr1, which we described earlier as di-
rect DOT1L target gene (5). This suggested that DOT1L
and H3K79me2 directly affected gene expression of mark-
ers for differentiated neurons, especially of UL, but not DL
marker gene expression.
As DOT1L influenced transcription of known genes con-
ferring UL identity at E12.5, we overexpressed DOT1L
at this developmental stage to analyze whether DOT1L
function was instructive for neuronal differentiation. We
used in utero electroporation (IUE) at E12.5 to overex-
press DOT1L, harvested brains at E14.5 and E16.5, and vi-
sualized electroporated cells by expression of RFP, which
was co-electroporated. We quantified the total number of
RFP-positive cells and determined the percentage of RFP-
positive cells that co-expressed either PAX6, TBR2, TBR1,
CTIP2 or SATB2. Quantitation of the fraction of double
positive cells was restricted to the main expression domains
of the respective marker genes. We did not observe alter-
ations in E14.5 brains that overexpress DOT1L compared
to the empty vector control electroporation (Supplemen-
tary Figure S8A). In contrast, at E16.5, we observed de-
creased expression of TBR1 (Figure 6D) upon DOT1L-
overexpression. In addition, we noticed thatRFP-cells over-
expressingDOT1L appeared in higher numbers in the lower
half of the cortical plate at E16.5, and fewer numbers in
the upper half of the cortex compared to control electro-
porated brains (Figure 6E). Moreover, a minor fraction
of SATB2-positive cells populated deeper locations than
in control brains (Figure 6E). We therefore quantified the
numbers of TBR1- and SATB2-positive cells in the entire
cortical plate, which we divided into 10 equal bins. SATB2-
positive cells significantly increased in the proportion of
SATB2/RFP-coexpressing cells in the deep cortical loca-
tion upon DOT1L-overexpression. TBR1-positive cells de-
creased significantly in more superficial bins after DOT1L-
overexpression as compared to controls (Figure 6E). As ex-
pected, these results showed that overexpression of DOT1L
at E12.5 did not result in significant alterations of the num-
ber of progenitors expressing PAX6 and TBR2, but that
increased DOT1L expression affected both, generation of
TBR1- and SATB2-positive cells. The former is slightly in-
hibited through DOT1L, the latter facilitated. However, the
overexpression of DOT1Lmost likely also impacted on dis-
tribution of TBR1 and SATB2 neurons, as the differences
in numbers were comparably mild. Especially the SATB2-
expression domain extended to the intermediate zone, indi-
cating that the migration of SATB2-positive neurons might
be hampered. In summary, the gain-of-function experiment
suggested that DOT1L acted not exclusively by regulating
cell cycle genes, but also by regulating specific developmen-
tal programs of neurons to ensure their proper generation
as well as distribution in the cortical plate.
The overexpression of DOT1L at E12.5 produced
slightly, but significantly more SATB2 neurons with al-
tered distribution in the cortical plate compared to con-
trols. The Satb2 gene had detectable H3K79me2 levels al-
ready at E12.5 (Figure 6A). We therefore hypothesized that
an earlier DOT1L function might prime progenitors for
a later SATB2 cell fate, implying that overexpression of
DOT1L at E12.5 only affected a small, responsive progen-
itor fraction. We used an inducible Nes-Cre driver line to
delete DOT1L before, around, and after E12.5 to resolve
a potential critical time at which DOT1L affected genera-
tion of SATB2-positive neurons, or generally neurogenesis.
Dot1l-cKO was induced by three consecutive tamoxifen in-
jections at (i) E9.5, E10.5, and E11.5, (ii) E11.5, E12.5, and
E13.5 and (iii) E13.5, E14.5, and E15.5 to interfere with
DOT1L expression during three different phases of corti-
cal neurogenesis (Supplementary Figure S8B). Brains were
harvested at E18.5 and expression of PAX6, TBR2, TBR1,
CTIP2, and SATB2 was quantified (Figure 7A, B). Dot1l-
cKO before E12.5 reduced the numbers of PAX6- and
TBR2-progenitors and let to differences in distribution of
TBR1-neurons. CTIP2-neurons did not change, but as ex-
pected the numbers of SATB2-neurons significantly de-
creased. In contrast, induction of the Dot1l-cKO around
E12.5 did not affect the numbers of progenitors, but led to
a significant increased generation of TBR1-, CTIP2-, and
SATB2-neurons, the latter of which also localized signif-
icantly more in DL. After E12.5, DOT1L-deficiency sig-
nificantly reduced the numbers of progenitors and TBR1-
neurons. SATB2-neurons did not change in numbers but
were less frequent in UL positions.
In summary, data from all three Dot1l-cKO mouse lines
and overexpression of DOT1L in the cerebral cortex pre-
sented in this study (Supplementary Figure S8C) support
a model in which DOT1L has different functions during
consecutive stages of cortical plate development. In essence,
DOT1L maintained the progenitor pool, and it was neces-
sary for proper distribution ofDLandULneurons.DOT1L
primed a SATB2-neuronal cell fate through its activity be-
fore E12.5. One hallmark of this early DOT1L-dependent
determination of SATB2 expression is the H3K79me2 en-
richment in this gene in early progenitors.
DISCUSSION
Our data show that the epigenetic chromatin modifier
DOT1L is implicated in the development of the cortical
plate, by maintaining the progenitor pool, and by affecting
neuronal differentiation. DOT1L methylates histone H3 at
K79, and if we correlate H3K79me2 pattern with DE genes,
it is tempting to speculate that this epigenetic modification
confers cellular commitment early during development, e.g.
to prepare a SATB2 neuronal phenotype, which becomes
apparent during later developmental stages.
The developmental advantage of using epigenetic traits to
propagate information about potential cell fate is that it can
be (i) established early in development, (ii) transmitted to
future generations of progenitors, and (iii) kept at basal lev-
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Figure 7. DOT1L primes SATB2-expression in the pre-neurogenic phase of cortical development. (A) Left panels: Representative immunostainings of
E18.5 forebrains for PAX6, TBR2, TBR1, CITP2, and SATB2 (red), and DAPI (blue) of ctrl (no Tmx) and Nes-Cre Dot1l-cKO animals (three injections
of Tmx at consecutive days starting at three different time points: Tmx E9.5-E11.5, Tmx E11.5–13.5, Tmx E13.5-E15.5). Scale bar: 50 m. Right panels:
Quantification of number of stained cells/mm2 within each individual bin out of 10 bins spanning the entire cortex in a width of 200 m for ctrl and
Nes-Cre Dot1l-cKO (ctrl n = 4 (white bars), Tmx E9.5-E11.5 n = 3, Tmx E11.5-E13.5 n = 3, Tmx E13.5-E15.5 n = 4 (gray bars)). (B) Total numbers
of PAX6, TBR1, CTIP2 or SATB2-positive cells at E18.5 in 200 m width of the cortex, as determined from the sum of positive cells for the respective
markers counted in A, comparing ctrl (white bars) and Nes-Cre Dot1l-cKO with cKO induced at the indicated different time points (Tmx E9.5-E11.5,
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epigenetic modifications are important mechanisms to ac-
tivate specific transcriptional programs in ESCs (51,52),
and they also operate in vivo to shape the cerebral cor-
tex. However, according to our RNA-seq data, H3K79me2
may not only have activating functions as suggested by
various reports (17,53,54), but may also lead to transcrip-
tional repression. We also reported reduced H3K79me2
levels at the Tbr1 gene in mice deficient for the DOT1L-
interaction partner AF9 (MLLT3, Super elongation com-
plex subunit) (5). In this regard, H3K79me2 is distinct from
activity-associated H3K4me3, which was reported to coin-
cide with H3K79me2 (55–58). In our data only a subset
of H3K4me3 marked genes carried also H3K79me2. We
cannot rule out that H3K79me1 or me3 mark the rest of
transcriptionally active genes. But our data most likely indi-
cate that H3K79me2 is associated with a specific chromatin
state, at genes with developmentally instructive functions
during cortical development. H3K79me2 marks essential
genes also in other developmentally restricted or commit-
ted stem cells (21,59,60). This co-occurrence can be inter-
preted that H3K79me2 has the potential to initiate, prime
and/or maintain specific transcriptional programs that im-
pact on cell fate decisions, in the cerebral cortex but also
in other stem cells. However, we can only conclude that the
histonemodification correlates with the observed transcrip-
tional changes, without ruling out that other DOT1L func-
tions than methylation of H3K79 are involved and/or re-
sponsible.
Our results show that DOT1L functions at various stages
of cortical development, and mainly activates transcrip-
tional programs in progenitors and differentiated neurons.
Others have reported that DOT1L influences the cell cy-
cle and suggested functions in either G1/S- or M-phase.
However, systematic mechanistic insight gained through
transcriptome analyses and identification of in vivo target
genes in mammalian cells are rare (61). We show here that
DOT1L affects G1/S- and M-phase transitions in neural
stem cells and increases expression of Vangl2 and Cenpj.
Both are novel DOT1L target genes that are associated
with asymmetric cell division and cell fate decision in cor-
tical development (49). VANGL2- and CENPJ-deficiency
results in altered orientation of the cleavage plane, M-phase
arrest, and premature differentiation. In addition, Cenpj
mutations are associated with microcephaly (62). We ob-
served an increased frequency of cleavage planes charac-
teristic for asymmetric cell division in progenitors resid-
ing in the DOT1L-deficient VZ, which might indicate the
relevance of the transcriptional regulation of Vangl2 and
Cenpj by DOT1L. It has been reported that H3K79me2
levels can vary during the cell cycle itself (61,63,64). How-
ever, these reported data are in part contradictory, and the
cell cycle dynamics of H3K79me2 are not evolutionary con-
served (65). It is thus impossible to ascertain whether vari-
ableH3K9me2 levels during different phases of the cell cycle
are responsible for the phenotype of Dot1l-cKO forebrains.
Our data suggest to us that DOT1L might prime early
born progenitors for adapting a specific phenotype for later
developmental stages. This notion is supported by vari-
ous observations: H3K79me2 was enriched in genes, which
are transcribed in the progenitor zones and in UL (Fig-
ure 3). In addition, DOT1L deficiency reduced transcrip-
tion of diverse Sox family member genes, in progenitors
and differentiated neurons, and led to reduced levels of
H3K79me2 at Sox4, Sox11 and Sox5 genes that are ac-
tive in differentiated neurons (Figure 4). Similarly, loss of
DOT1L reduced transcription and H3K79me2 levels of
Satb2, Pou3f3, Cux1, and Cux2, all of which are mostly
active in UL neurons, but these effects were not observed
for selected DL genes (Figure 6). Furthermore, SATB2-
expressing neurons significantly increased after overexpres-
sion of DOT1L at E12.5 in vivo (Figure 6) despite un-
changed numbers of progenitors. Moreover, three mouse
models in which DOT1L-deficiency occurred during pre-
neurogenic phase before E12.5 had a defect in neurogenesis
of SATB2-neurons, whereas TBR1 and CTIP2 neurons re-
siding in DL distributed differently within the cortical plate
compared to controls. This observation that interferingwith
DOT1L function in the pre-neurogenic phase leads to re-
duced numbers of SATB2-neurons is a strong argument in
favor for an early priming of UL-cell fate through this epi-
genetic modifier (Supplementary Figure S8C).
Importantly, deletion ofDOT1L in the threemousemod-
els and at different developmental time points revealed that
this enzyme has probably multiple functions during de-
velopment. Compared to the loss of DOT1L in the pre-
neurogenic phase (Foxg1-Cre, Emx1-Cre, Nes-Cre at E9.5–
11.5), the cKO at later stages gave slightly different pat-
terns in the genesis of progenitors and neurons. Nes-Cre
induced cKO between E11.5 and E13.5 did not result in
different numbers of progenitors. It is tempting to specu-
late that progenitors are permissive toward loss of DOT1L
at this stage. However, as we also observed increasing cell
numbers of TBR1-, CTIP2-, and SATB2-neurons it seems
also likely that cells enter the cell cycle in higher numbers
and that loss of DOT1L accounts for a facilitated exit for
differentiation into DL and UL subtypes in these stages.
This view is supported by the altered cell cycle in Foxg1-
Cre cKOmice (Figure 2E–G), in which progenitors seem to
follow this pattern. Increased differentiation into SATB2-
expressing neurons around E12.5 might be favored as the
early progenitors acquired the information to adopt this cell
fate before the cKO was induced. Loss of DOT1L at the
late neurogenic phase between E13.5 and E15.5 decreased
the progenitor pool compared to controls. In contrast to
the cKOs at earlier stages, we observed decreased generation
of TBR1-expressing neurons during late neurogenesis upon
DOT1L deletion. We speculate that this particular fraction
of cells might localize to UL, according to our recently re-
ported observation on AF9-deficient mice (5). AF9 inter-
acts withDOT1L, and loss ofAF9 increased TBR1-positive
cells specifically in superficial positions. As progenitors re-
ceived instructions to adopt a SATB2-cell fate during early
development, the numbers of these neurons did not decrease
uponDot1l-cKO in this later developmental stage.However,
as the distribution of SATB2-neurons significantly changed
in the cortical plate upon DOT1L-deficiency in late neuro-
genesis, we conclude that DOT1L does not only function to
balance the progenitor pool and to prime specific neuronal
identity, but that it is also necessary for proper neuronal dis-
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